Latest Insider Transactions at Natures Sunshine Products Inc (NATR)
This section provides a real-time view of insider transactions for Natures Sunshine Products Inc (NATR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of NATURES SUNSHINE PRODUCTS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of NATURES SUNSHINE PRODUCTS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 06
2021
|
Terrence Moorehead Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,147
-1.46%
|
$72,058
$14.72 P/Share
|
|
Oct 06
2021
|
Terrence Moorehead Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,077
+3.59%
|
-
|
|
Sep 22
2021
|
Shirley Wu Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,968
+50.0%
|
-
|
|
Sep 15
2021
|
Willem Mesdag > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
2,407,801
-82.1%
|
-
|
|
Sep 14
2021
|
Terrence Moorehead Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
15,284
-4.32%
|
$229,260
$15.75 P/Share
|
|
Aug 20
2021
|
Terrence Moorehead Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,859
-1.08%
|
$65,603
$17.03 P/Share
|
|
Aug 20
2021
|
Terrence Moorehead Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,804
+2.67%
|
-
|
|
Aug 20
2021
|
Joseph W Baty EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,768
-1.21%
|
$30,056
$17.03 P/Share
|
|
Aug 20
2021
|
Joseph W Baty EVP & Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,481
+2.99%
|
-
|
|
Jul 16
2021
|
Joseph W Baty EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,074
-0.73%
|
$37,332
$18.26 P/Share
|
|
Jul 16
2021
|
Joseph W Baty EVP & Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,260
+1.83%
|
-
|
|
Jul 01
2021
|
Tariq Hassan Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,119
+50.0%
|
-
|
|
May 05
2021
|
Robert B Mercer Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,188
+4.99%
|
-
|
|
May 05
2021
|
Mary Beth Springer Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,188
+7.03%
|
-
|
|
May 05
2021
|
Richard D Moss Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,188
+15.15%
|
-
|
|
May 05
2021
|
Robert D Straus Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,188
+12.06%
|
-
|
|
May 05
2021
|
Heidi Wissmiller Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,188
+27.52%
|
-
|
|
May 05
2021
|
John Christopher Teets Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,188
+8.45%
|
-
|
|
May 05
2021
|
Lily Zou Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,188
+20.46%
|
-
|
|
May 03
2021
|
Joseph W Baty EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,413
-1.23%
|
$68,260
$20.6 P/Share
|
|
May 03
2021
|
Joseph W Baty EVP & Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,650
+3.0%
|
-
|
|
May 03
2021
|
Terrence Moorehead Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
13,025
-1.26%
|
$260,500
$20.6 P/Share
|
|
May 03
2021
|
Terrence Moorehead Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
33,092
+3.09%
|
-
|
|
Apr 12
2021
|
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
711
+1.75%
|
-
|
|
Apr 12
2021
|
Terrence Moorehead Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,002
-0.3%
|
$19,038
$19.64 P/Share
|
|
Apr 12
2021
|
Terrence Moorehead Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,628
+2.27%
|
-
|
|
Apr 12
2021
|
Robert B Mercer Director |
BUY
Grant, award, or other acquisition
|
Direct |
972
+1.66%
|
-
|
|
Apr 12
2021
|
Heidi Wissmiller Director |
BUY
Grant, award, or other acquisition
|
Direct |
258
+4.72%
|
-
|
|
Apr 12
2021
|
Richard D Moss Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,380
+4.6%
|
-
|
|
Apr 12
2021
|
Joseph W Baty EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
178
-0.13%
|
$3,382
$19.64 P/Share
|
|
Apr 12
2021
|
Joseph W Baty EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,977
+1.47%
|
-
|
|
Apr 12
2021
|
Robert D Straus Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,360
+3.3%
|
-
|
|
Apr 12
2021
|
John Christopher Teets Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,515
+2.38%
|
-
|
|
Apr 12
2021
|
Lily Zou Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,131
+5.94%
|
-
|
|
Apr 12
2021
|
Mary Beth Springer Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,169
+1.47%
|
-
|
|
Apr 06
2021
|
Terrence Moorehead Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,668
-1.13%
|
$73,360
$20.13 P/Share
|
|
Apr 06
2021
|
Terrence Moorehead Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,320
+2.79%
|
-
|
|
Apr 06
2021
|
Joseph W Baty EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,042
-0.79%
|
$20,840
$20.13 P/Share
|
|
Apr 06
2021
|
Joseph W Baty EVP & Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,260
+3.13%
|
-
|
|
Apr 01
2021
|
Terrence Moorehead Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,897
-3.63%
|
$226,043
$19.5 P/Share
|
|
Mar 30
2021
|
Joseph W Baty EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,389
-1.84%
|
$43,002
$18.95 P/Share
|
|
Mar 29
2021
|
Terrence Moorehead Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,339
+7.96%
|
$510,102
$18.58 P/Share
|
|
Mar 29
2021
|
Terrence Moorehead Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,588
-1.19%
|
$64,584
$18.58 P/Share
|
|
Mar 26
2021
|
Joseph W Baty EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,953
+9.06%
|
$233,154
$18.25 P/Share
|
|
Mar 18
2021
|
Terrence Moorehead Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,919
-1.21%
|
$207,461
$19.83 P/Share
|
|
Mar 18
2021
|
Terrence Moorehead Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
31,456
+3.38%
|
-
|
|
Mar 18
2021
|
Joseph W Baty EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,010
-0.86%
|
$38,190
$19.83 P/Share
|
|
Mar 18
2021
|
Joseph W Baty EVP & Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,222
+3.37%
|
-
|
|
Mar 02
2021
|
Terrence Moorehead Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,270
-0.8%
|
$38,590
$17.66 P/Share
|
|
Mar 02
2021
|
Terrence Moorehead Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,319
+3.17%
|
-
|